Chronic Lymphocytic Leukemia | Summer Oncology Nursing Series: Chronic Lymphocytic Leukemia — Session 2

Featuring perspectives from Dr John M Pagel and Ms Lesley Camille Ballance, including the following topics: Introduction (0:00) The recent history of CLL treatment (2:09) Bruton tyrosine kinase (BTK) inhibitors (19:35) Case: A woman in her early 50s with previously untreated CLL who receives acalabrutinib — Lesley Camille Ballance, MSN, FNP-BC (23:31) Key data sets on BTK inhibitors in CLL (38:04) Case: A woman in her mid-40s with CLL who was initially observed off treatment — Ms Ballance (41:55) Case: A man in his early 60s with favorable-risk, IGHV-mutated CLL — 13q deletion — Ms Ballance (47:49) Case: A woman in her early 70s with multiregimen-relapsed CLL — Ms Balance (51:55) Key data sets on emerging therapies for CLL (54:01) CME information and select publications